SCHEMBL20037582

SCHEMBL20037582

Cc1ccc(N2CCC3(CC2)COC3)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.43
CYP11B2 P19099 3/20 0.43
PRMT5 O14744 1/20 0.39
LRRK2 Q5S007 1/20 0.39
ELANE P08246 1/20 0.38
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
RORC P51449 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 1/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24747253 0.86 VNN1 (0.42) LRRK2ALDH1A1MAPTSMN1; SMN2RAB9A
SCHEMBL18053868 0.81 PIK3CA (0.49) CYP11B1CYP11B2PRMT5PIK3CAMTOR
SCHEMBL20038068 0.81 CYP11B1 (0.43) CYP11B1CYP11B2PRMT5LRRK2PIK3CA
SCHEMBL24745808 0.81 CHRNB2 (0.42) LRRK2ELANECHRNB2CHRNA4CHRNB4
SCHEMBL23103355 0.81 PRMT5 (0.41) CYP11B1CYP11B2PRMT5LRRK2PIK3CA
SCHEMBL23108897 0.81 PRMT5 (0.46) CYP11B1CYP11B2PRMT5LRRK2PIK3CA
SCHEMBL20249241 0.81 CYP11B1 (0.40) CYP11B1CYP11B2PRMT5LRRK2PIK3CA
SCHEMBL17207204 0.80 ELANE (0.41) ELANEPIK3CAMTORALDH1A1MAPT
SCHEMBL14930376 0.80 MAPT (0.39) LRRK2ELANEALDH1A1MAPTSMN1; SMN2
SCHEMBL17664588 0.79 ELANE (0.41) ELANEJAK2JAK1AOC3CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed